1-171090009-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000896149.1(FMO3):​c.-6-2644C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 151,684 control chromosomes in the GnomAD database, including 6,963 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6963 hom., cov: 31)

Consequence

FMO3
ENST00000896149.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0650

Publications

7 publications found
Variant links:
Genes affected
FMO3 (HGNC:3771): (flavin containing dimethylaniline monoxygenase 3) Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.[provided by RefSeq, Jan 2016]
FMO3 Gene-Disease associations (from GenCC):
  • trimethylaminuria
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • severe primary trimethylaminuria
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.559 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000896149.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FMO3
ENST00000896149.1
c.-6-2644C>G
intron
N/AENSP00000566208.1
FMO1-AS1
ENST00000653116.1
n.542+78095G>C
intron
N/A
FMO1-AS1
ENST00000664920.1
n.681+31741G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44518
AN:
151570
Hom.:
6943
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.293
Gnomad AMR
AF:
0.371
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.576
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.305
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.274
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.294
AC:
44564
AN:
151684
Hom.:
6963
Cov.:
31
AF XY:
0.299
AC XY:
22139
AN XY:
74114
show subpopulations
African (AFR)
AF:
0.215
AC:
8909
AN:
41344
American (AMR)
AF:
0.372
AC:
5677
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1002
AN:
3466
East Asian (EAS)
AF:
0.576
AC:
2973
AN:
5158
South Asian (SAS)
AF:
0.309
AC:
1487
AN:
4806
European-Finnish (FIN)
AF:
0.305
AC:
3190
AN:
10444
Middle Eastern (MID)
AF:
0.257
AC:
74
AN:
288
European-Non Finnish (NFE)
AF:
0.300
AC:
20404
AN:
67920
Other (OTH)
AF:
0.276
AC:
582
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1547
3094
4640
6187
7734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.170
Hom.:
359
Bravo
AF:
0.293
Asia WGS
AF:
0.438
AC:
1517
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.89
DANN
Benign
0.50
PhyloP100
-0.065

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1736560; hg19: chr1-171059150; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.